ArticleFrontiers in oncology2021

A Multicenter Retrospective Study on the Prognosis of Stage III Unresectable Mutant Non-Small Cell Lung Cancer With Tyrosine Kinase Inhibitors Therapy.

Ranpu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.